PMID: 11922953Mar 30, 2002Paper

Pharmacophore modeling of cytochromes P450

Advanced Drug Delivery Reviews
Marcel J de Groot, Sean Ekins

Abstract

Understanding the binding of ligands in the active site of a membrane-bound protein is difficult in the absence of a crystal structure. When these proteins are the enzymes involved in drug metabolism, it leaves little option but to use site-directed mutagenesis and in vitro studies to provide critical information relating to determinants of binding affinity. Pharmacophore models and three-dimensional quantitative structure-activity relationships have been used either alone or in combination with protein homology models to provide this information for cytochrome P450s. At present, their application has been directed to the major enzymes but this may escalate in future as more in vitro data are generated for other P450s. The following review outlines the methodologies and models as well as future prospects for applying these technologies to P450s in the hope that future drugs will be selected with increased metabolic stability and fewer incidences of undesirable drug-drug interactions.

References

Sep 17, 1977·Lancet·A MahgoubR L Smith
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Mar 1, 1992·Chemical Research in Toxicology·L KoymansG M Donné-Op den Kelder
Jan 1, 1992·Critical Reviews in Toxicology·S A Wrighton, J C Stevens
Dec 1, 1989·Journal of Molecular Graphics·G G Ferenczy, G M Morris
Nov 1, 1968·Archives of Biochemistry and Biophysics·C HanschF Helmer
Sep 1, 1994·Journal of Chemical Information and Computer Sciences·P I NagyA J Hopfinger
Jan 1, 1993·Drug Metabolism Reviews·L KoymansN P Vermeulen
Mar 24, 1993·Biochemical Pharmacology·K BrøsenS Loft
Mar 8, 1996·Biochemical Pharmacology·L PichardP Maurel
Feb 1, 1996·Journal of Computer-aided Molecular Design·M Recanatini
Jun 1, 1996·Journal of Computer-aided Molecular Design·T I Oprea, A E García
Jan 1, 1997·Chemical Research in Toxicology·M J de GrootN P Vermeulen
Apr 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M J de GrootN P Vermeulen
May 1, 1997·Journal of Computer-aided Molecular Design·G D Szklarz, J R Halpert
May 13, 1998·British Journal of Clinical Pharmacology·K KobayashiY Kuroiwa
Jul 15, 1998·British Journal of Clinical Pharmacology·J O Miners, D J Birkett
Aug 26, 1999·Drug Metabolism Reviews·S Ekins, S A Wrighton
Nov 24, 1999·Archives of Biochemistry and Biophysics·M HeW F Trager
Mar 7, 2000·Journal of Computer-aided Molecular Design·F De RienzoP G De Benedetti
Apr 7, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T LightfootG T Tucker

❮ Previous
Next ❯

Citations

Jan 25, 2008·Journal of Computer-aided Molecular Design·John H Block, Douglas R Henry
Apr 23, 2003·Trends in Pharmacological Sciences·Sean EkinsJ Andrew Williams
Feb 13, 2004·Drug Discovery Today·Andrej BugrimYuri Nikolsky
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Julianna OláhJeremy N Harvey
Sep 27, 2012·Ergonomics·Anirban ChowdhurySougata Karmakar
Apr 23, 2005·SAR and QSAR in Environmental Research·U Norinder
Jun 23, 2009·SAR and QSAR in Environmental Research·T RingstedJ Niemelä
Feb 17, 2005·Bioinformatics·Svava Osk JónsdóttirSøren Brunak
Mar 20, 2004·European Journal of Biochemistry·Marcel AmichotJean-Baptiste Bergé
Jul 22, 2011·Journal of Bioinformatics and Computational Biology·Reiji Teramoto, Tsuyoshi Kato
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·John O MinersPeter I Mackenzie
Jul 17, 2004·Chemical & Pharmaceutical Bulletin·Toshimasa TanakaYoshio Yamamoto
Jun 10, 2003·Clinical Pharmacokinetics·Collen M MasimirembwaTommy B Andersson
Mar 7, 2014·Journal of Chemical Information and Modeling·Tim Geppert, Bernd Beck
Feb 26, 2009·Expert Opinion on Drug Metabolism & Toxicology·Yojiro Sakiyama
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Sean EkinsTatiana Nikolskaya
Aug 28, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kunal Roy, Partha Pratim Roy
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·Judith C Madden, Mark T D Cronin
Jul 28, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D F V LewisP S Goldfarb
May 11, 2015·Advanced Drug Delivery Reviews·Lars OlsenFlemming Steen Jørgensen
Mar 2, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Agnieszka PotęgaZofia Mazerska
Mar 7, 2009·Chemical Reviews·Stefan Balaz
Feb 22, 2012·Journal of Chemical Information and Modeling·Johannes KirchmairRobert C Glen
Jun 6, 2007·British Journal of Pharmacology·S EkinsB Testa
Jan 1, 2012·Molecular Informatics·Tao ZhangDongqing Wei
Aug 4, 2004·Current Opinion in Chemical Biology·Andrew M Davis, Robert J Riley
Feb 1, 2006·Environmental Toxicology and Pharmacology·Ruth HylandHan van de Waterbeemd
Jul 27, 2004·Journal of Chemical Information and Computer Sciences·Huili YaoDaniel S Sem
May 21, 2013·Expert Opinion on Drug Metabolism & Toxicology·Chin Eng OngRusli Ismail
Mar 1, 2012·Bioorganic & Medicinal Chemistry·Svava Ósk JónsdóttirJay R Niemelä
Nov 30, 2013·Regulatory Toxicology and Pharmacology : RTP·Jos G BessemsJosé-Manuel Zaldívar-Comenges
Sep 13, 2012·ACS Medicinal Chemistry Letters·Jonas Boström
Mar 23, 2011·Drug Metabolism and Drug Interactions·Yamsani Shravan KumarYamsani Madhusudan Rao
Jan 10, 2003·Journal of Cellular Biochemistry·Inge SchusterRomano T Kroemer
Jan 2, 2014·Pharmacological Reviews·Gregory SliwoskiEdward W Lowe
Apr 6, 2005·Journal of Biomolecular Screening·Rieko ArimotoEric M Gifford
May 18, 2005·Journal of Enzyme Inhibition and Medicinal Chemistry·Petr HodekMarie Stiborová
Aug 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sean EkinsRichard K Harrison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Drug Metabolism & Toxicology
Judith C Madden, Mark T D Cronin
Advanced Drug Delivery Reviews
Eric Y ZhangPeter W Swaan
Drug Metabolism and Disposition : the Biological Fate of Chemicals
Sean Ekins, Jon A Erickson
© 2022 Meta ULC. All rights reserved